EUVIMEDOdkrijte EUVIMED
Crossref

Incidence Rate of Therapeutic Apheresis: Analysis of a Therapeutic Apheresis Database to Use as a Benchmarking Tool

Joan Cid iD, Eva Rodríguez, Sandra Ortega, Anna M Garcia, Jordi Comas, Paola Charry, Miquel Lozano iD, Rosa Ramos

Journal of Clinical Apheresis · 2025

DOI: 10.1002/jca.70024 ↗

At a glance

Journal article in Journal of Clinical Apheresis, 2025. Written by Joan Cid and 7 co-authors. Institution: Apheresis Unit, Department of Hemotherapy and Hemostasis, ICAMS, Clínic Barcelona, Barcelona, Catalonia, Spain. Major MEDLINE topics: Benchmarking, Blood Component Removal. 16 references.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Benchmarking in apheresis medicine focuses on the collection of hematopoietic cells, where specific key performance indicators have been recommended to be used as an internal quality control of processes. The aim of this study was to collect data regarding the number of therapeutic apheresis procedures performed in Catalonia, Spain, and to compare this data with those from other countries. A database was created to collect therapeutic apheresis procedures from 2019 to 2023 in Catalonia, Spain. Similar articles about this topic were obtained using Medical Subject Headings in PubMed. To compare therapeutic apheresis performance among countries, the incidence rate of therapeutic apheresis was calculated as the number of therapeutic apheresis procedures per 1000 people per year. In a 5‐year period, 26 897 therapeutic apheresis were performed in a 7.6 million population with an incidence rate of therapeutic apheresis of 0.71 per 1000 people per year. The incidence rate varied by as much as 10.1 times among the studies, from 0.07 in a USA study to 0.71 in the present study. When only European studies were compared, the incidence rate varied by as much as 1.65 times among the studies, from 0.43 in a Norwegian study to 0.71 in the present study. We report for the first time the therapeutic apheresis activity performed in Catalonia, Spain. Moreover, the incidence rate of therapeutic apheresis, calculated as the number of therapeutic apheresis procedures performed per 1000 people per year, is an objective indicator, easy to calculate, that can help in benchmarking therapeutic apheresis utilization.

Subjects

MeSH terms (MEDLINE)

BenchmarkingBlood Component RemovalHumansSpainIncidenceDatabases, Factual

Author keywords

apheresisbenchmarkingblood component removalmanagement auditplasma exchangeprogram evaluationtherapeutics

Authors and institutions

  • Apheresis Unit, Department of Hemotherapy and Hemostasis, ICAMS, Clínic Barcelona, Barcelona, Catalonia, Spain.
  • Department of Nephrology, Hospital del Mar, IMIM, Barcelona, Catalonia, Spain.
  • Banc de Sang i Teixits, Barcelona, Catalonia, Spain.
  • Organització Catalana de Trasplantaments (OCATT), Barcelona, Catalonia, Spain.
  • Department of Nephrology, ICNU, Clínic Barcelona, Barcelona, Catalonia, Spain.

ORCID profiles: Joan Cid, Miquel Lozano

Cite

APA

Cid, J., Rodríguez, E., Ortega, S., Garcia, A. M., Comas, J., Charry, P., Lozano, M., & Ramos, R. (2025). Incidence Rate of Therapeutic Apheresis: Analysis of a Therapeutic Apheresis Database to Use as a Benchmarking Tool. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70024

Vancouver

Cid J, Rodríguez E, Ortega S, Garcia AM, Comas J, Charry P, et al. Incidence Rate of Therapeutic Apheresis: Analysis of a Therapeutic Apheresis Database to Use as a Benchmarking Tool. Journal of Clinical Apheresis. 2025. doi:10.1002/jca.70024

BibTeX
@article{Cid2025,
  author = {Cid, Joan and Rodríguez, Eva and Ortega, Sandra and Garcia, Anna M and Comas, Jordi and Charry, Paola and Lozano, Miquel and Ramos, Rosa},
  title = {Incidence Rate of Therapeutic Apheresis: Analysis of a Therapeutic Apheresis Database to Use as a Benchmarking Tool},
  journal = {Journal of Clinical Apheresis},
  year = {2025},
  doi = {10.1002/jca.70024}
}
Start for free →